Epstein Secrets

Answer (10/8), "It's really not US versus China. What it's really about is democracy versus authoritarianism. ... What we have seen under Chairman Xi...is we have seen them just break all of their promises, break all of their commitments. They've broken their promises to Hong Kong, to the people t

said Regeneron's early trials data "found patients given the antibody cocktail cleared the virus faster with reduced symptoms. But critics like Dr. Rick Bright fear the emergency approval process is being politicized." Former Biomedical Advanced Research and Development Authority Director Rick Bright said,

stigall> (10/8), "It's really not US versus China. What it's really about is democracy versus authoritarianism.... What we have seen under Chairman Xi...is we have seen them just break all of their promises, break all of their commitments. They've broken their promises to Hong Kong, to the people t

said Regeneron's early trials data "found patients given the antibody cocktail cleared the virus faster with reduced symptoms. But critics like Dr. Rick Bright fear the emergency approval process is being politicized." Former Biomedical Advanced Research and Development Authority Director Rick Bright said,

Answer (10/8), "It's really not US versus China. What it's really about is democracy versus authoritarianism. ... What we have seen under Chairman Xi...is we have seen them just break all of their promises, break all of their commitments. They've broken their promises to Hong Kong, to the people

said Regeneron's early trials data "found patients given the antibody cocktail cleared the virus faster with reduced symptoms. But critics like Dr. Rick Bright fear the emergency approval process is being politicized." Former Biomedical Advanced Research and Development Authority Director Rick Bright said,

Answer (10/8), "It's really not US versus China. What it's really about is democracy versus authoritarianism. ... What we have seen under Chairman Xi...is we have seen them just break all of their promises, break all of their commitments. They've broken their promises to Hong Kong, to the people

said Regeneron's early trials data "found patients given the antibody cocktail cleared the virus faster with reduced symptoms. But critics like Dr. Rick Bright fear the emergency approval process is being politicized." Former Biomedical Advanced Research and Development Authority Director Rick Bright said,